Daiwa Securities Group’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-700
Closed -$15K – 1351
2023
Q4
$15K Buy
+700
New +$12.9K ﹤0.01% 1146
2022
Q4
– Sell
-9,075
Closed -$230K – 1385
2022
Q3
$230K Buy
9,075
+957
+12% +$33.6K ﹤0.01% 925
2022
Q2
$270K Sell
8,118
-1,867
-19% -$79.3K ﹤0.01% 932
2022
Q1
$720K Buy
9,985
+2,600
+35% +$187K ﹤0.01% 779
2021
Q4
$678K Buy
7,385
+300
+4% +$35.9K ﹤0.01% 796
2021
Q3
$898K Buy
7,085
+995
+16% +$145K 0.01% 707
2021
Q2
$1.01M Buy
6,090
+820
+16% +$133K 0.01% 635
2021
Q1
$958K Buy
5,270
+300
+6% +$69.6K 0.01% 633
2020
Q4
$994K Buy
4,970
+1,685
+51% +$343K 0.01% 574
2020
Q3
$720K Buy
3,285
+3,125
+1,953% +$662K 0.01% 594
2020
Q2
$25K Hold
160
– – ﹤0.01% 1015
2020
Q1
$25K Sell
160
-90
-36% -$10.5K ﹤0.01% 996
2019
Q4
$21K Hold
250
– – ﹤0.01% 1012
2019
Q3
$17K Buy
+250
New +$16.5K ﹤0.01% 1002

Other funds holding TDOC

Daiwa Securities Group's TDOC Position: Q1 2024 in Review

Daiwa Securities Group sold out of Teladoc Health (TDOC) in Q1 2024, closing a stake of 700 shares — an estimated $15K sold.

Daiwa Securities Group first reported a position in TDOC in Q3 2019 and held it in 14 quarters. The position peaked at $1.01M in Q2 2021. 426 funds tracked by Wall St. Rank hold TDOC as of Q1 2024.

  • Daiwa Securities Group reported no remaining Teladoc Health position as of Q1 2024 after selling out during the quarter.
  • Daiwa Securities Group sold 700 Teladoc Health shares in Q1 2024, an estimated $15K.
  • Daiwa Securities Group first reported a position in Teladoc Health in Q3 2019 and held it in 14 quarters.
  • Daiwa Securities Group's Teladoc Health position peaked at $1.01M in Q2 2021.
  • 426 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2024.

Based on Daiwa Securities Group's 13F filing for Q1 2024, filed 2 May 2024.